MJ Biotech (MJTV) 10-K 2018 FY Annual report

EXHIBIT 32.1

Section 1350 Certification

In connection with the Annual Report of MJ Biotech Inc. (the “ Company ” ) on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (the “ Report ” ), I, Maxine Pierson, Chief Executive Officer and Chief Financial Officer of the Company, do each hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2. The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

/s/ Maxine Pierson         July 10, 2019

Maxine Pierson, Chief Executive Officer, principal executive officer, Chief Financial Officer, principal financial and accounting officer